KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Other financing activities (2018 - 2023)

Pacific Biosciences Of California has reported Other financing activities over the past 6 years, most recently at $50000.0 for Q4 2023.

  • For Q4 2023, Other financing activities changed N/A year-over-year to $50000.0; the TTM value through Dec 2024 reached $539000.0, down 86.8%, while the annual FY2023 figure was $7.4 million, N/A changed from the prior year.
  • Other financing activities for Q4 2023 was $50000.0 at Pacific Biosciences Of California, down from $489000.0 in the prior quarter.
  • Over five years, Other financing activities peaked at $32.2 million in Q4 2020 and troughed at -$30.1 million in Q4 2021.
  • A 5-year average of $3.9 million and a median of $1.4 million in 2019 define the central range for Other financing activities.
  • Biggest five-year swings in Other financing activities: skyrocketed 24469.47% in 2020 and later crashed 193.59% in 2021.
  • Year by year, Other financing activities stood at $131000.0 in 2019, then skyrocketed by 24469.47% to $32.2 million in 2020, then tumbled by 193.59% to -$30.1 million in 2021, then surged by 111.76% to $3.5 million in 2022, then plummeted by 98.59% to $50000.0 in 2023.
  • Business Quant data shows Other financing activities for PACB at $50000.0 in Q4 2023, $489000.0 in Q3 2023, and $3.5 million in Q3 2022.